[Gene therapy for kidney transplantation].
Isaka
Yoshitaka
Y
Imai
Enyu
E
D000069594:Abatacept; D000208:Acute Disease; D000818:Animals; D002908:Chronic Disease; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006084:Graft Rejection / Q000517:prevention & control / Q000628:therapy*; D006085:Graft Survival; D017228:Hepatocyte Growth Factor / Q000235:genetics* / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D007108:Immune Tolerance; D018796:Immunoconjugates / Q000235:genetics / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced / Q000628:therapy; D016030:Kidney Transplantation; D016328:NF-kappa B; D009399:Nephrons; D013601:T-Lymphocytes
D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D016328:NF-kappa B; D017228:Hepatocyte Growth Factor; D000069594:Abatacept